<SEC-DOCUMENT>0001140361-24-048224.txt : 20241202
<SEC-HEADER>0001140361-24-048224.hdr.sgml : 20241202
<ACCEPTANCE-DATETIME>20241202210240
ACCESSION NUMBER:		0001140361-24-048224
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20241127
FILED AS OF DATE:		20241202
DATE AS OF CHANGE:		20241202

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			ELMS STEVE
		CENTRAL INDEX KEY:			0001250195
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36728
		FILM NUMBER:		241520773

	MAIL ADDRESS:	
		STREET 1:		888 SEVENTH AVE
		STREET 2:		29TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10106

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADMA BIOLOGICS, INC.
		CENTRAL INDEX KEY:			0001368514
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				562590442
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		C/O ADMA BIOLOGICS, INC.
		STREET 2:		465 STATE ROUTE 17
		CITY:			RAMSEY
		STATE:			NJ
		ZIP:			07446
		BUSINESS PHONE:		(201) 478-5552

	MAIL ADDRESS:	
		STREET 1:		C/O ADMA BIOLOGICS, INC.
		STREET 2:		465 STATE ROUTE 17
		CITY:			RAMSEY
		STATE:			NJ
		ZIP:			07446

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	R&R ACQUISITION VI, INC
		DATE OF NAME CHANGE:	20060707
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2024-11-27</periodOfReport>

    <issuer>
        <issuerCik>0001368514</issuerCik>
        <issuerName>ADMA BIOLOGICS, INC.</issuerName>
        <issuerTradingSymbol>ADMA</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001250195</rptOwnerCik>
            <rptOwnerName>ELMS STEVE</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>489 5TH AVENUE</rptOwnerStreet1>
            <rptOwnerStreet2>10TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10017</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>false</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2024-11-27</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>M</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>9000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>10.8</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>2124671</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See footnote</value>
                    <footnoteId id="F1"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>76441</value>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>10.8</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2024-11-27</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>M</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>9000</value>
                    <footnoteId id="F3"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F4"/>
            </exerciseDate>
            <expirationDate>
                <value>2025-01-30</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>9000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">These shares are owned by Aisling Capital II LP (&quot;Aisling&quot;), which is a fund that was established in 2007 with a 10-year life. Mr. Elms is Aisling's designee for nomination to the Board. As a Managing Member of Aisling Capital Partners, LLC (&quot;Aisling Partners&quot;), a control person of Aisling, and as a member of the investment committee of Aisling Capital Partners, LP (&quot;Aisling GP&quot;), Mr. Elms may be deemed to be the beneficial owner of shares of common stock owned of record by Aisling. Mr. Elms disclaims beneficial ownership of Aisling's investment in the Company and Aisling Partners' ownership of the Company's options, except to the extent of his pecuniary interest therein.</footnote>
        <footnote id="F2">Includes, as of the transaction date, (i) 12,020 restricted stock units (&quot;RSUs&quot;) granted on February 26, 2024, which will vest fully on February 26, 2025, subject to the Reporting Person's continued service as of such vesting date; and (ii) 64,421 shares of common stock owned by the Reporting Person.</footnote>
        <footnote id="F3">The Reporting Person is exercising these options due to their near-term expiration date.</footnote>
        <footnote id="F4">These options vested monthly over a period of 24 months from the date of grant, becoming fully vested on January 30, 2017.</footnote>
    </footnotes>

    <remarks>Exhibit 24 - Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Steve Elms, by Michael A. Goldstein as Attorney-in-fact</signatureName>
        <signatureDate>2024-12-02</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>ef20039402_ex24.htm
<DESCRIPTION>EXHIBIT 24
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit, a Broadridge Company
         Document created using Broadridge PROfile 24.11.1.5268
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">

  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-weight: bold;"> Exhibit 24<br>
      </div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">LIMITED POWER OF ATTORNEY</div>
      <div style="text-align: center; font-weight: bold;">FOR SECTION 16(a) REPORTING</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints Adam S. Grossman, President and Chief Executive Officer, and Michael A. Goldstein, Senior Director,
        General Counsel, of ADMA Biologics, Inc. (the &#8220;Company&#8221;), and each of them, as the undersigned&#8217;s true and lawful attorney-in-fact (the &#8220;Attorney-in Fact&#8221;), with full power of substitution and resubstitution, with the power to act alone for the
        undersigned and in the undersigned&#8217;s name, place and stead, in any and all capacities to:</div>
      <div>&#160;</div>
      <div style="text-align: justify;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; prepare, execute and submit to the Securities and Exchange Commission (&#8220;SEC&#8221;), any national securities exchange and the Company any and all reports (including any amendment thereto) of the undersigned
        required or considered advisable under Section 16(a) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), and the rules and regulations thereunder, with respect to the equity securities of the Company, including Form 3 (Initial Statement of
        Beneficial Ownership of Securities), Form 4 (Statement of Changes in Beneficial Ownership), and Form 5 (Annual Statement of Changes in Beneficial Ownership); and</div>
      <div>&#160;</div>
      <div style="text-align: justify;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; seek or obtain, as the undersigned&#8217;s representative and on the undersigned&#8217;s behalf, information regarding transactions in the Company&#8217;s equity securities from any third party, including the Company and
        any brokers, dealers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such third party to release any such information to the Attorney-in-Fact.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">&#160;The undersigned acknowledges that:</div>
      <div>&#160;</div>
      <div style="text-align: justify;">1.&#160;&#160;&#160;&#160;&#160;&#160; &#160; this Limited Power of Attorney authorizes, but does not require, the Attorney-in-Fact to act at his discretion on information provided to such Attorney-in-Fact without independent verification of such
        information;</div>
      <div>&#160;</div>
      <div style="text-align: justify;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; any documents prepared and/or executed by the Attorney-in-Fact on behalf of the undersigned pursuant to this Limited Power of Attorney will be in such form and will contain such information as the
        Attorney-in-Fact, in his discretion, deems necessary or desirable;</div>
      <div>&#160;</div>
      <div style="text-align: justify;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; neither the Company nor the Attorney-in-Fact assumes any liability for the undersigned&#8217;s responsibility to comply with the requirements of Section 16 of the Exchange Act, any liability of the undersigned
        for any failure to comply with such requirements, or any liability of the undersigned for disgorgement of profits under Section 16(b) of the Exchange Act; and</div>
      <div>&#160;</div>
      <div style="text-align: justify;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; this Limited Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned&#8217;s obligations under Section 16 of the Exchange Act, including, without, limitation,
        the reporting requirements under Section 16(a) of the Exchange Act.</div>
      <div style="text-align: justify; text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">The undersigned hereby grants to the Attorney-in-Fact full power and authority to do and perform each and every act and thing requisite, necessary or convenient to be done in connection with the
        foregoing, as fully, to all intents and purposes, as the undersigned might or could do in person, hereby ratifying and confirming all that the Attorney-in-Fact, or his substitute or substitutes, shall lawfully do or cause to be done by authority of
        this Limited Power of Attorney.</div>
      <div style="text-align: justify; text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Limited Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 or 5 with respect to the undersigned&#8217;s holdings of and
        transactions in equity securities of the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Attorney-in-Fact.</div>
      <div style="text-align: justify; text-indent: 36pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;">This Limited Power of Attorney shall be governed by and construed in accordance the laws of the State of Delaware without regard to the laws that might otherwise govern under applicable principles
        of conflicts of laws thereof.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be executed as of March 28, 2024.</div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" align="center" style="border-collapse: collapse; width: 100%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" id="zd44b7357158544f0a9845118a9048e74">

            <tr>
              <td style="width: 23%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 12%; vertical-align: top;">
                <div>Signature:</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div><u>/s/ Steven A. Elms</u></div>
              </td>
            </tr>
            <tr>
              <td style="width: 23%; vertical-align: top;" colspan="1">&#160;</td>
              <td style="width: 12%; vertical-align: top;">
                <div>Print Name:</div>
              </td>
              <td style="width: 65%; vertical-align: top;">
                <div>Steven A. Elms</div>
              </td>
            </tr>

        </table>
      </div>
      <div>&#160;</div>
      <div> <br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
